A pilot trial of irinotecan, 5-fluorouracil, and leucovorin [folinic acid] combined with the anti-angiogenesis agent tetrathiomolybdate in metastatic colorectal carcinoma (UMCC 0075)
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 05 Feb 2012
At a glance
- Drugs Tetrathiomolybdate (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 19 Dec 2005 New trial record.